The Current Ratio as of November 2025 (TTM) for Alseres Pharmaceuticals, Inc. (ALSE) is 0.20

According to Alseres Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.20. This represents a change of 55.69% compared to the average of 0.13 of the last 4 quarters.

Alseres Pharmaceuticals, Inc. (ALSE) Historical Current Ratio (quarterly & annually)

How has ALSE Current Ratio performed in the past?

The mean historical Current Ratio of Alseres Pharmaceuticals, Inc. over the last ten years is 0.70. The current 0.20 Current Ratio has changed 2.71% with respect to the historical average. Over the past ten years (40 quarters), ALSE's Current Ratio was at its highest in in the September 2005 quarter at 5.67. The Current Ratio was at its lowest in in the March 2011 quarter at 0.00.

Alseres Pharmaceuticals, Inc. (ALSE) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Alseres Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Alseres Pharmaceuticals, Inc. (ALSE) Average Current Ratio

How has ALSE Current Ratio performed in the past?

The current Current Ratio of Alseres Pharmaceuticals, Inc. (ALSE) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Alseres Pharmaceuticals, Inc. (ALSE) Current Ratio vs. Peers

How is ALSE’s Current Ratio compared to its peers?

Alseres Pharmaceuticals, Inc.’s Current Ratio is less than Achiko AG (0.35), less than Lotus Ventures Inc. (0.36), less than Evolva Holding S.A. (8.34), less than FluroTech Ltd. (0.70), greater than Digicann Ventures Inc. (0.05), less than TuHURA Biosciences, Inc. (0.83), less than Phoenix Life Sciences International Limited (1.76), greater than Aquarius Surgical Technologies Inc. (0.05), greater than Kiromic BioPharma, Inc. (0.16), less than Hemogenyx Pharmaceuticals Plc (0.72),

Build a custom stock screener for Alseres Pharmaceuticals, Inc. (ALSE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alseres Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Alseres Pharmaceuticals, Inc. (ALSE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Alseres Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.